Search

Search Constraints

You searched for: Author/Creator Goodhand, James R.

Search Results

3. Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy (IMSAT) therapeutic drug monitoring study. Issue 8 (29th August 2022)

4. Oral Iron Treatment Response and Predictors in Anaemic Adolescents and Adults with IBD: A Prospective Controlled Open-Label Trial. (15th December 2016)

5. Quality improvement project identifies factors associated with delay in IBD diagnosis. Issue 3 (23rd June 2020)

6. Root‐cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease. Issue 2 (7th November 2020)

7. Understanding anti‐TNF treatment failure: does serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predict therapeutic outcome to anti‐TNF therapies in biologic‐naïve patients with active luminal Crohn's disease?. Issue 5 (29th June 2022)

8. Validating the positivity thresholds of drug‐tolerant anti‐infliximab and anti‐adalimumab antibody assays. Issue 1 (23rd November 2020)